Hotel101-Niseko Topping Off Ceremony Marks Progress for 482-Room Hotel Opening in December 2026
Written by Emily J. Thompson, Senior Investment Analyst
Source: Newsfilter
Updated: 52 minutes ago
0mins
Source: Newsfilter
- Project Milestone: The topping off ceremony for Hotel101-Niseko signifies the nearing completion of its 482-room structure, with an expected opening in December 2026 to cater to the winter tourism peak.
- Innovative Business Model: The hotel introduces a 'condotel' model that not only offers exceptional value but also aims to generate dual revenue streams through the sale of hotel units and ongoing operations, enhancing its market competitiveness.
- Comprehensive Amenities: The property will feature all-day dining, meeting spaces, an indoor pool, and an onsen, targeting families, couples, and groups, thereby enriching the guest experience.
- Market Positioning: Located in the renowned ski destination of Niseko, Hotel101-Niseko is set to become a key attraction for international visitors, further solidifying the region's status as Asia's premier alpine destination.
DD.N$0.0000%Past 6 months

No Data
Analyst Views on DD
Wall Street analysts forecast DD stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for DD is 56.10 USD with a low forecast of 44.00 USD and a high forecast of 93.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Wall Street analysts forecast DD stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for DD is 56.10 USD with a low forecast of 44.00 USD and a high forecast of 93.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Current: 39.660

Current: 39.660

RBC Capital
Arun Viswanathan
Outperform
downgrade
$100 -> $48
Reason
RBC Capital
Arun Viswanathan
RBC Capital analyst Arun Viswanathan lowered the firm's price target on DuPont to $48 from $100 and keeps an Outperform rating on the shares. RBC Capital remains positive on DuPont after its Electronics spin, as DuPont is an 8%-10% EPS grower before buybacks, the analyst tells investors in a research note.
Equal Weight
downgrade
$80 -> $44
Reason
Morgan Stanley lowered the firm's price target on DuPont to $44 from $80 and keeps an Equal Weight rating on the shares.
Overweight
maintain
$44 -> $45
Reason
KeyBanc analyst Aleksey Yefremov raised the firm's price target on DuPont to $45 from $44 and keeps an Overweight rating on the shares. The firm says that while DuPont's second half of the year numbers are somewhat muddled by a reset of numbers postspin, it sees the update as a positive for the story. Growth shifted down from 2% average in the first half of the year, but remains positive, KeyBanc notes.
UBS raised the firm's price target on DuPont to $46 from $44 and keeps a Buy rating on the shares. DuPont posted a second half beat and raise, delivering growth out of the gate in a tough macro environment, the analyst tells investors in a research note.
About DD
DuPont de Nemours, Inc. is engaged in providing advanced solutions that help transform industries. The Company serves various markets, including healthcare, water, construction, and transportation. The Company’s IndustrialsCo segment is a provider of engineered products and integrated solutions primarily serving medical, including packaging and specialty medical devices, water filtration, worker safety, automotive, including electric vehicles, aerospace and building product end markets. The IndustrialsCo segment offers medical packaging, medical silicones, specialty medical devices, water purification and separation, water filtration and purification resins, flexible packaging products, nonwovens, aramids, construction materials, auto adhesives and fluids.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.